Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 1—January 2026

Research

Detection of Novel Thermotolerant Tepidimonas sp. Bacteria in Human Respiratory Specimens, Hong Kong, China, 2024

Kelvin Hei-Yeung Chiu, Shuk-Ching Wong, Edwin Kwan-Yeung Chiu, Raymond Hon Man Ng, Jonathan Hon-Kwan Chen, Jordan Yik-Hei Fong, Lithia Lai-Ha Yuen, Simon Yung-Chun So, David Christopher Lung, Vincent Chi-Chung Cheng, Kwok-Yung YuenComments to Author , and Jade Lee-Lee TengComments to Author 
Author affiliation: Queen Mary Hospital, Hong Kong, China (K.H.-Y. Chiu, S.-C. Wong, E.K.-Y. Chiu, R.H.-M. Ng, J.H.-K. Chen, L.L.-H. Yuen, S.Y.-C. So, V.C.-C. Cheng); University of Hong Kong, Hong Kong (S.-C. Wong, J.H.-K. Chen, J.Y.-H. Fong, K.-Y. Yuen, J.L.-L. Teng); Queen Elizabeth Hospital, Hong Kong (D.C. Lung); Hong Kong Children’s Hospital, Hong Kong (D.C. Lung)

Main Article

Table 2

Demographic characteristics of 41 patients from whom Tepidimonas spp. bacteria were detected in respiratory specimens, Hong Kong, China, 2024*

Characteristics Value
Median age, y (range)
 70 (15–97)
Sex
F 23 (56.1)
M
 18 (43.9)
Underlying conditions
Hypertension 15 (36.6)
Diabetes mellitus 7 (17.1)
Hyperlipidemia 10 (24.4)
Cardiovascular disease 9 (22.0)
Renal impairment 7 (17.1)
Cerebral vascular accident 1 (2.4)
Chronic lung disease 10 (24.4)
Chronic liver disease 7 (17.1)
Solid organ malignancy 17 (41.5)
Hematologic malignancy 1 (2.4)
Autoimmune disease
 1 (2.4)
Timing of positive growth
Outpatient or <48 h of admission 24 (58.5)
>48 h after admission
 17 (41.5)
Clinical signs and symptoms
Fever 13 (31.7)
Cough 14 (34.1)
Sputum 11 (26.8)
Shortness of breath
 13 (31.7)
Chest radiography
Not done 2 (4.9)
Unremarkable 14 (34.1)
Consolidation or pulmonary infiltrates 11 (26.8)
Pleural effusion 8 (19.5)
Chronic lung changes
 10 (24.4)
Blood parameters, median (range)
Leukocytes, × 109 cells/L 8.34 (1.77–23.10)
Neutrophils, × 109 cells/L 5.94 (1.29–20.95)
C-reactive protein, mg/dL 5.21 (0.17–18.53)

*Values are no. (%) except as indicated.

Main Article

Page created: December 30, 2025
Page updated: January 29, 2026
Page reviewed: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external